Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Autoimmune Disorders

  Free Subscription


1 Am J Kidney Dis
3 BMC Neurol
6 Diabetes
3 J Autoimmun
6 J Clin Endocrinol Metab
1 J Immunol
1 J Neuroimmunol
2 J Neurol
4 Mult Scler
1 N Engl J Med
3 Neurology
3 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Kidney Dis

  1. SAHA MK, Massicotte-Azarniouch D, Reynolds ML, Mottl AK, et al
    Glomerular Hematuria and the Utility of Urine Microscopy: A Review.
    Am J Kidney Dis. 2022;80:383-392.
    PubMed         Abstract available

    BMC Neurol

  2. KOLCAVA J, Rajdova A, Vlckova E, Stourac P, et al
    Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report.
    BMC Neurol. 2022;22:313.
    PubMed         Abstract available

  3. NANATSUE K, Takahashi M, Itaya S, Abe K, et al
    A case of Miller Fisher syndrome with delayed onset peripheral facial nerve palsy after COVID-19 vaccination: a case report.
    BMC Neurol. 2022;22:309.
    PubMed         Abstract available

  4. LI X, Xu H, Zheng Z, Ouyang H, et al
    The risk factors of neuropathic pain in neuromyelitis optica spectrum disorder: a retrospective case-cohort study.
    BMC Neurol. 2022;22:304.
    PubMed         Abstract available


  5. SOOKAROMDEE P, Wiwanitkit V
    Comment on D'Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806.
    Diabetes. 2022;71:e13.

  6. D'ADDIO F, Fiorina P
    Response to Comment on D'Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806.
    Diabetes. 2022;71:e14.

  7. CHEN M, Hu R, Cavinato C, Zhuang ZW, et al
    Fibronectin-integrin alpha5 signaling in vascular complications of type 1 diabetes.
    Diabetes. 2022 Jun 30. pii: 147154. doi: 10.2337/db21-0958.
    PubMed         Abstract available

  8. ITO Y, Sun R, Yagimuma H, Taki K, et al
    Protein Tyrosine Phosphatase 1B Deficiency Improves Glucose Homeostasis in Insulin-Dependent Diabetes Mellitus Treated with Leptin.
    Diabetes. 2022 Jun 24. pii: 147141. doi: 10.2337/db21-0953.
    PubMed         Abstract available

  9. LEUNG SS, Borg DJ, McCarthy DA, Boursalian TE, et al
    Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells.
    Diabetes. 2022 Jun 17. pii: 147090. doi: 10.2337/db22-0177.
    PubMed         Abstract available

  10. MACDONALD MJ, Ansari IH, Riedemann AS, Stoker SW, et al
    A Novel Intron-Encoded Neuropilin-1 Isoform in Pancreatic Islets Associated With Very Young Age of Onset of Type 1 Diabetes.
    Diabetes. 2022 Jun 17. pii: 147085. doi: 10.2337/db21-1070.
    PubMed         Abstract available

    J Autoimmun

  11. YU C, Li P, Dang X, Zhang X, et al
    Lupus nephritis: new progress in diagnosis and treatment.
    J Autoimmun. 2022 Aug 20:102871. doi: 10.1016/j.jaut.2022.102871.
    PubMed         Abstract available

  12. REILY C, Rice T, Crossman DK, Rizk DV, et al
    Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
    J Autoimmun. 2022;132:102883.
    PubMed         Abstract available

  13. ROUSSELIN C, Amoura Z, Faguer S, Bataille P, et al
    Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy.
    J Autoimmun. 2022;132:102889.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  14. MAIO A, Maiorino MI, Longo M, Scappaticcio L, et al
    Change in circulating levels of endothelial progenitor cells and sexual function in women with type 1 diabetes.
    J Clin Endocrinol Metab. 2022 May 18. pii: 6588130. doi: 10.1210.
    PubMed         Abstract available

  15. NOWAK C, Lind M, Sumnik Z, Pelikanova T, et al
    Intralymphatic GAD-alum (Diamyd(R)) improves glycaemic control in Type 1 diabetes with HLA DR3-DQ2.
    J Clin Endocrinol Metab. 2022 Jun 6. pii: 6602344. doi: 10.1210.
    PubMed         Abstract available

  16. WANG CH, Lu WL, Chiang SL, Tsai TH, et al
    T cells mediate kidney tubular injury via impaired PDHA1 and Autophagy in type 1 diabetes.
    J Clin Endocrinol Metab. 2022 Jun 22. pii: 6613175. doi: 10.1210.
    PubMed         Abstract available

  17. ULDALL TORP NM, Bruun NH, Christensen PA, Handberg A, et al
    TSH-receptor antibodies in early pregnancy.
    J Clin Endocrinol Metab. 2022 Jun 23. pii: 6614623. doi: 10.1210.
    PubMed         Abstract available

  18. ROSSI A, Venema A, Haarsma P, Feldbrugge L, et al
    A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.
    J Clin Endocrinol Metab. 2022;107:e3612-e3623.
    PubMed         Abstract available

  19. ZENZ S, Regittnig W, Boulgaropoulos B, Augustin T, et al
    Effect of Liraglutide Treatment on Whole Body Glucose Fluxes in C-peptide Positive Type 1 Diabetes During Hypoglycaemia.
    J Clin Endocrinol Metab. 2022 Jul 14. pii: 6644078. doi: 10.1210.
    PubMed         Abstract available

    J Immunol

  20. WOODS J, Pemberton SE, Largent AD, Chiang K, et al
    Cutting Edge: Systemic Autoimmunity in Murine STAT3 Gain-of-Function Syndrome Is Characterized by Effector T Cell Expansion in the Absence of Overt Regulatory T Cell Dysfunction.
    J Immunol. 2022 Aug 22. pii: jimmunol.2100920. doi: 10.4049/jimmunol.2100920.
    PubMed         Abstract available

    J Neuroimmunol

  21. ISHIZUCHI K, Takizawa T, Ohnuki Y, Sekiguchi K, et al
    Immunodeficiency in patients with thymoma-associated myasthenia gravis.
    J Neuroimmunol. 2022;371:577950.
    PubMed         Abstract available

    J Neurol

  22. GUEGUEN A, Hijazi B, Zuber K, Deschamps R, et al
    Generalization of ocular myasthenia gravis 10 years after onset.
    J Neurol. 2022 Aug 24. pii: 10.1007/s00415-022-11316.
    PubMed         Abstract available

  23. BARNAY M, Duval F, Sole G, Carla L, et al
    Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study.
    J Neurol. 2022 Aug 22. pii: 10.1007/s00415-022-11345.
    PubMed         Abstract available

    Mult Scler

  24. YOUNG CA, Mills RJ, Langdon D, Rog DJ, et al
    Measuring coping in multiple sclerosis: The Coping Index-MS.
    Mult Scler. 2022 Aug 24:13524585221114004. doi: 10.1177/13524585221114004.
    PubMed         Abstract available

  25. ALTOKHIS AI, Hibbert AM, Allen CM, Mougin O, et al
    Longitudinal clinical study of patients with iron rim lesions in multiple sclerosis.
    Mult Scler. 2022 Aug 24:13524585221114750. doi: 10.1177/13524585221114750.
    PubMed         Abstract available

  26. BROWNLEE WJ, Wolf C, Hartung HP, Dingermann T, et al
    Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations.
    Mult Scler. 2022 Aug 24:13524585221116269. doi: 10.1177/13524585221116269.
    PubMed         Abstract available

  27. MEATON I, Altokhis A, Allen CM, Clarke MA, et al
    Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.
    Mult Scler. 2022 Aug 26:13524585221118677. doi: 10.1177/13524585221118677.
    PubMed         Abstract available

    N Engl J Med

  28. STEINMAN L, Fox E, Hartung HP, Alvarez E, et al
    Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
    N Engl J Med. 2022;387:704-714.
    PubMed         Abstract available


  29. LOPEZ-JIMENEZ A, Gutierrez-Gutierrez G, Guerra-Hiraldo JD, Kurtis MM, et al
    Teaching Video NeuroImage: Hung-Up Reflex in Stiff Limb Syndrome.
    Neurology. 2022;99:356.

  30. HWANG S, Garcia-Dominguez MA, Fitzgerald KC, Saylor DR, et al
    Association of Multiple Sclerosis Prevalence With Sociodemographic, Health Systems, and Lifestyle Factors on a National and Regional Level.
    Neurology. 2022 Aug 24. pii: WNL.0000000000200962.
    PubMed         Abstract available

  31. BRENTON JN, Florenzo B, Koshiya H, Min S, et al
    Six-Minute Walk as a Measure of Walking Capacity and Endurance in Patients With Pediatric-Onset Multiple Sclerosis.
    Neurology. 2022 Aug 19. pii: WNL.0000000000201098.
    PubMed         Abstract available

    PLoS One

  32. CRABTREE E, Uribe K, Smith SM, Roberts D, et al
    Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy.
    PLoS One. 2022;17:e0270972.
    PubMed         Abstract available

  33. LI Y, Yu X, Zhang W, Lv J, et al
    Epidemiological characteristics and pathological changes of primary glomerular diseases.
    PLoS One. 2022;17:e0272237.
    PubMed         Abstract available

  34. CHOI YJ, Kim C, Choi EW, Lee SH, et al
    MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.
    PLoS One. 2022;17:e0270416.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  35. MEYER T, Shimon D, Youssef S, Yankovitz G, et al
    NAD(+) metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity.
    Proc Natl Acad Sci U S A. 2022;119:e2211310119.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.